98%
921
2 minutes
20
As a principal adjuvant therapy for glioblastoma (GBM), radiotherapy (RT) is instrumental in extending patient survival. Radiosensitizers could enhance the cytotoxic effects of radiation on tumor cells. However, their accumulation and penetration are significantly hindered by the blood-brain barrier (BBB) and weak convection and diffusion due to elevated interstitial pressure and the dense extracellular matrix within GBM, which reduces the effectiveness of RT. To maximize the radiosensitizing efficiency, it is imperative to develop a delivery system capable of crossing the BBB, specifically targeting GBM, and penetrating the center of the GBM. We propose utilizing cell membrane camouflage to achieve BBB crossing and tumor targeting and the self-propulsion ability of nanomotors to promote diffusion and overcome convection within GBM, thereby facilitating deep tumor penetration. We first clarify that the hollow structure with an opening exhibits a stronger propulsive force than the Janus structure under identical conditions. Subsequently, we developed a facile method to prepare nanomotors featuring a hollow structure with an opening. By camouflaging the nanomotors with hybrid cell membranes with BBB-crossing and tumor-targeting capabilities, we create biomimetic nanomotors (Bio-motors). Results show our Bio-motors possess enhanced diffusion capacity and achieve deep penetration under reverse pressure gradients, which also effectively traverse the BBB, target GBM, and penetrate deeply within the tumor. Notably, the Bio-motors enhance radiosensitivity and inhibit GBM growth, thereby prolonging the median survival of GBM-bearing mice. Our Bio-motors will significantly boost RT efficacy for GBM patients and could be readily adapted into versatile carriers for tumor therapy due to the modular design.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/jacs.5c09121 | DOI Listing |
J Nanobiotechnology
August 2025
Sichuan Higher Education Institute Key Laboratory of Major Disease Target Discovery and Protein Drug Development, School of Bioscience and Technology, Chengdu Medical College, Chengdu, 610500, P. R. China.
Thrombotic diseases pose life-threatening risks, yet current thrombolytic therapies face limitations including poor targeting and bleeding risks. To address this, ultrasound-activatable nanomotors (hBT-Pt@Pm) were developed through the integration of hollow BaTiO₃/Pt Schottky heterojunctions with platelet membrane (Pm) coatings. The hollow structure enhances piezocatalytic efficiency by shortening charge migration distances, while Pt deposition improves carrier separation, collectively boosting reactive oxygen species (ROS) generation under ultrasound.
View Article and Find Full Text PDFJ Am Chem Soc
July 2025
State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Tianjin Institutes of Health Science, Institute of Radiation Medicine, Chinese Academy of Medical
As a principal adjuvant therapy for glioblastoma (GBM), radiotherapy (RT) is instrumental in extending patient survival. Radiosensitizers could enhance the cytotoxic effects of radiation on tumor cells. However, their accumulation and penetration are significantly hindered by the blood-brain barrier (BBB) and weak convection and diffusion due to elevated interstitial pressure and the dense extracellular matrix within GBM, which reduces the effectiveness of RT.
View Article and Find Full Text PDFNanoscale Horiz
August 2025
Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy.
The integration of gold nanoparticles (AuNPs) with lipid bilayers gives rise to powerful synergistic effects arising from nanoscale interactions. Precise control over these interactions enables the rational design of hybrid AuNP-lipid membrane multifunctional composites, unlocking advanced analytical tools and cutting-edge biomedical applications. From a materials design standpoint, functionalizing AuNPs with lipid membranes reduces cytotoxicity and enhances stability in complex biological environments.
View Article and Find Full Text PDFBiomaterials
November 2025
Department of General Surgery, First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. Electronic address:
Peritoneal metastasis (PM) is a terminal stage of gastrointestinal cancers, often resulting in poor survival outcomes. Traditional treatments like cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have shown some effectiveness but are associated with significant risks. This study presents a novel nanomotor-based drug delivery system (M@MnO-Au-mSiO@CDDP) designed to enhance the efficacy of PM treatment.
View Article and Find Full Text PDFBioact Mater
April 2025
3B's Research Group-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Guimarães, 4805-017, Portugal.
Enzyme-powered micro/nanomotors (EMNMs) represent cutting-edge research taking advantage of enzymes as biocatalysts to provide a driving force for micro/nanomotors. Up to now, EMNMs have been designed to be powered by catalase, urease, lipase, collagenase, compound enzymes, . They not only have good biocompatibility and biosafety but also possess the unique ability to utilize physiologically relevant fuel to achieve autonomous propulsion through catalytic reactions.
View Article and Find Full Text PDF